News & Events
A specialized eye test can predict disease progression in MS
Retinal thickness can be used as a measure to predict worsening disability in MS
Effectiveness of memory rehabilitation in people with MS
Review shows previous measures of memory rehabilitation were not reflective of daily life
Sex-specific differences in comorbid conditions in MS
Researchers find men with MS experience more chronic health problems at the time of diagnosis
Alternative to natalizumab in people at risk of a brain infection
Swedish study favours rituximab over fingolimod for those at risk of progressive multifocal leukoencephalopathy
Long term support for MSIF’s Du Pré Grants from the Netherlands
Stichting MS Research will fund two of MSIF’s Du Pré grants
MSIF at MENACTRIMS
MSIF holds first meeting for MS organisations at MENACTRIMS
World MS Day is coming
World MS Day takes places on 25 May 2016 with the tagline ‘MS doesn’t stop me…’
Does ethnicity play a role in neuromyelitis optica (NMO)?
The role of genes in NMO appears to vary depending on a person’s ethnicity
Coffee consumption and risk of multiple sclerosis
Research suggests that high consumption of coffee may protect brain cells from damage
Natalizumab is more effective than fingolimod in reducing relapses
French researchers compare oral and injectable drugs for relapsing-remitting MS
New drug ozanimod could be an effective alternative to fingolimod
An international study looks at the safety and efficacy of a drug similar to fingolimod
AEDEM COCEMFE launches program to support people at home
A Spanish government funded scheme will help people to overcome different barriers